Stoxx Europe 50
5.146,66
PKT
-5,87
PKT
-0,11
%
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.22 | BBVA Hold | Deutsche Bank AG | |
| 31.03.22 | LOréal Overweight | JP Morgan Chase & Co. | |
| 31.03.22 | SAP Outperform | Credit Suisse Group | |
| 31.03.22 | Siemens Buy | Jefferies & Company Inc. | |
| 31.03.22 | HSBC Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | Santander Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.03.22 | Siemens Overweight | JP Morgan Chase & Co. | |
| 30.03.22 | Unilever Outperform | Credit Suisse Group | |
| 30.03.22 | Sanofi Outperform | Credit Suisse Group | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Sanofi Buy | UBS AG | |
| 30.03.22 | Iberdrola SA Buy | Goldman Sachs Group Inc. | |
| 30.03.22 | Enel Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Outperform | Bernstein Research | |
| 30.03.22 | UBS Sector Perform | RBC Capital Markets | |
| 30.03.22 | UBS Outperform | RBC Capital Markets | |
| 30.03.22 | BBVA Outperform | RBC Capital Markets | |
| 30.03.22 | Santander Sector Perform | RBC Capital Markets | |
| 30.03.22 | HSBC Outperform | RBC Capital Markets | |
| 30.03.22 | BNP Paribas Outperform | RBC Capital Markets | |
| 30.03.22 | ING Group Sector Perform | RBC Capital Markets | |
| 30.03.22 | UBS Buy | Jefferies & Company Inc. | |
| 30.03.22 | UBS Hold | Jefferies & Company Inc. | |
| 30.03.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 29.03.22 | RELX Outperform | Credit Suisse Group | |
| 29.03.22 | Sanofi Buy | UBS AG | |
| 29.03.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 29.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.03.22 | VINCI Overweight | JP Morgan Chase & Co. | |
| 29.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. |